×
Home Current Archive Editorial board
News Contact
Review paper

Provoked venous thromboembolism during ten-year follow up at the Clinical Centre University of Sarajevo

By
Akif Mlačo Orcid logo ,
Akif Mlačo
Contact Akif Mlačo

Department of Angiology, Clinic for Heart, Blood Vessel and Rheumatic Diseases, Clinical Center University of Sarajevo , Sarajevo , Bosnia and Herzegovina

Nejra Mlačo ,
Nejra Mlačo

School of Medicine, University of Sarajevo , Sarajevo , Bosnia and Herzegovina

Demir Bejtović ,
Demir Bejtović

Department of Cardiology, Clinic for Heart, Blood Vessel and Rheumatic Diseases, Clinical Center University of Sarajevo , Sarajevo , Bosnia and Herzegovina

Muhamed Spužić ,
Muhamed Spužić

Department of Cardiology, Clinic for Heart, Blood Vessel and Rheumatic Diseases, Clinical Center University of Sarajevo , Sarajevo , Bosnia and Herzegovina

Alen Džubur ,
Alen Džubur

Department of Cardiology, Clinic for Heart, Blood Vessel and Rheumatic Diseases, Clinical Center University of Sarajevo , Sarajevo , Bosnia and Herzegovina

Edin Begić
Edin Begić

Department of Cardiology, General Hospital ‘’Prim.dr. Abdulah Nakaš’’ , Sarajevo , Bosnia and Herzegovina

Department of Pharmacology, School of Medicine, Sarajevo School of Science and Technology , Sarajevo , Bosnia and Herzegovina

Abstract

Aim
To determine risk factors for deep vein thrombosis (DVT) in hospitalized patients in a 10-year follow-up.
Methods
In this observational study data were collected from the disease history of patients admitted to the Department of Angiology of the Clinical Centre University of Sarajevo in the period of 10 years (2008-2017). Of 6246 hospitalized patients, 1154 were with established diagnosis of DVT and included in the study as a basic inclusion criterion.
Results
Provoked venous thromboembolism was recorded in 45.75% of hospitalized patients. In 54.25% cases DVT was classified as idiopathic; in the remaining cases with DVT external risk factors were identified. Every fourth patient had a history of malignancy, and this risk factor was significantly more common among women and younger patients. Cancer of female reproductive organs, colon, lung, breast and prostate cancer were most common. One of 10 women had DVT during pregnancy or postpartum period. Out of the total number, 10.9% patients had DVT after surgery, 2.3% after injury. DVT was found in 1.6% of drug addicts. Rethrombosis was diagnosed in 5.2% patients within a year, while 9.2 % patients had rethrombosis within five years.
Conclusion
Provoked venous thromboembolism is an entity that can be prevented. Malignancy and surgical treatment are the most common risk factors and these patients should be treated with special care. The creation of a register of patients with venous thromboembolism in Bosnia and Herzegovina would enable the development of a preventive strategy in the groups of patients at risk.

References

1
Heit J. Epidemiology of venous thromboembolism. Nat Rev Cardiol 2015:464–74.
2
Stone J, Hangge P, Albadawi H, Wallace A, Shamoun F, Knuttien M, et al. Deep vein thrombosis: pathogenesis, diagnosis, and medical management. Cardiovasc Diagn Ther 2017:276-S84.
3
Brownson K, Brahmandam A, Huynh N, Reynolds J, Fares W, Lee A, et al. Characteristics of provoked deep venous thrombosis in a tertiary care center. J Vasc Surg Venous Lymphat Disord 2017:477–84.
4
Lj B. Guidelines on diagnosis, treatment and prevention of venous thrombosis. Cardiol Croat 2016:351–74.
5
Scarvelis D, Wells P. Diagnosis and treatment of deep-vein thrombosis. CMAJ 2006:1087–92.
6
Kucher N. Clinical practice. Deep-vein thrombosis of the upper extremities. N Engl J Med 2011:861–9.
7
Baekgaard N. Incidence and location of deep vein thrombosis in the lower extremities: what do we know. Phlebolymphology 2017:97–104.
8
Baron J, Gridley G, Weiderpass E, Nyrén O. Linet M. Venous thromboembolism and cancer. Lancet 1998:1077–80.
9
Khan F, Vaillancourt C, Bourjeily G. Diagnosis and management of deep vein thrombosis in pregnancy. BMJ 2017:2344.
10
Ouriel K, Green R, Greenberg R, Dg C. The anatomy of deep venous thrombosis of the lower extremity. J Vasc Surg 2000:895–900.
11
Lee A. Management of thrombosis in cancer: primary prevention and secondary prophylaxis. Br J Haematol 2005:291–302.
12
Mclendon K, Attia M. Deep Venous Thrombosis (DVT) Risk Factors 2019.
13
Bevis P, Smith F. Deep vein thrombosis. Surgery 2016:159–64.
14
Hansson P, Sörbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Acta Inform Med 2000:769–74.
15
Moheimani F, De J. Venous thromboembolism: classification, risk factors, diagnosis, and management. ISRN Hematol 2011:124610.
16
Mcrae S, Tran H, Schulman S, Ginsberg J, Kearon C. Effect of patient’s sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet 2006:371–8.

Citation

Authors retain copyright. This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.